Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | Enapotamab vedotin |
Trade Name | |
Synonyms | AXL-107-MMAE|HuMax-Axl-ADC |
Drug Descriptions |
Enapotamab vedotin (HuMax-Axl-ADC) is an antibody-drug conjugate comprising an AXL targeted antibody linked to the anti-microtubule compound MMAE, which potentially decreases tumor growth (J Clin Oncol 35, 2017 (suppl; abstr TPS2605), PMID: 32148495, PMID: 31600169). |
DrugClasses | AXL Antibody 5 |
CAS Registry Number | 1912424-97-5 |
NCIT ID | C132017 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Enapotamab vedotin | Enapotamab vedotin | 0 | 1 |